vs

Side-by-side financial comparison of Dexcom (DXCM) and Workday, Inc. (WDAY). Click either name above to swap in a different company.

Workday, Inc. is the larger business by last-quarter revenue ($2.4B vs $1.3B, roughly 1.9× Dexcom). Dexcom runs the higher net margin — 21.2% vs 10.4%, a 10.9% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 12.6%). Over the past eight quarters, Workday, Inc.'s revenue compounded faster (12.5% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Workday, Inc. is a leading global enterprise cloud software provider that develops and distributes human capital management, financial management, and enterprise resource planning solutions. It caters primarily to mid-sized and large organizations across sectors including education, healthcare, finance, and technology, with operations spanning North America, Europe, and Asia Pacific.

DXCM vs WDAY — Head-to-Head

Bigger by revenue
WDAY
WDAY
1.9× larger
WDAY
$2.4B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+9.0% gap
DXCM
21.6%
12.6%
WDAY
Higher net margin
DXCM
DXCM
10.9% more per $
DXCM
21.2%
10.4%
WDAY
Faster 2-yr revenue CAGR
WDAY
WDAY
Annualised
WDAY
12.5%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
DXCM
DXCM
WDAY
WDAY
Revenue
$1.3B
$2.4B
Net Profit
$267.3M
$252.0M
Gross Margin
62.9%
Operating Margin
25.6%
10.6%
Net Margin
21.2%
10.4%
Revenue YoY
21.6%
12.6%
Net Profit YoY
153.6%
30.6%
EPS (diluted)
$0.67
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
WDAY
WDAY
Q1 26
$1.3B
Q4 25
$1.3B
$2.4B
Q3 25
$1.2B
$2.3B
Q2 25
$1.2B
$2.2B
Q1 25
$1.0B
$2.2B
Q4 24
$1.1B
$2.2B
Q3 24
$994.2M
$2.1B
Q2 24
$1.0B
$2.0B
Net Profit
DXCM
DXCM
WDAY
WDAY
Q1 26
$267.3M
Q4 25
$267.3M
$252.0M
Q3 25
$283.8M
$228.0M
Q2 25
$179.8M
$68.0M
Q1 25
$105.4M
$94.0M
Q4 24
$151.7M
$193.0M
Q3 24
$134.6M
$132.0M
Q2 24
$143.5M
$107.0M
Gross Margin
DXCM
DXCM
WDAY
WDAY
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
WDAY
WDAY
Q1 26
25.6%
Q4 25
25.6%
10.6%
Q3 25
20.1%
10.6%
Q2 25
18.4%
1.7%
Q1 25
12.9%
3.4%
Q4 24
17.0%
7.6%
Q3 24
15.3%
5.3%
Q2 24
15.7%
3.2%
Net Margin
DXCM
DXCM
WDAY
WDAY
Q1 26
21.2%
Q4 25
21.2%
10.4%
Q3 25
23.5%
9.7%
Q2 25
15.5%
3.0%
Q1 25
10.2%
4.3%
Q4 24
13.6%
8.9%
Q3 24
13.5%
6.3%
Q2 24
14.3%
5.4%
EPS (diluted)
DXCM
DXCM
WDAY
WDAY
Q1 26
$0.67
Q4 25
$0.67
$0.94
Q3 25
$0.70
$0.84
Q2 25
$0.45
$0.25
Q1 25
$0.27
$0.34
Q4 24
$0.37
$0.72
Q3 24
$0.34
$0.49
Q2 24
$0.35
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
WDAY
WDAY
Cash + ST InvestmentsLiquidity on hand
$917.7M
$6.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$8.9B
Total Assets
$6.3B
$17.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
WDAY
WDAY
Q1 26
$917.7M
Q4 25
$917.7M
$6.8B
Q3 25
$1.8B
$8.2B
Q2 25
$1.2B
$8.0B
Q1 25
$904.9M
$8.0B
Q4 24
$606.1M
$7.2B
Q3 24
$621.2M
$7.4B
Q2 24
$939.2M
$7.2B
Total Debt
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$3.0B
Stockholders' Equity
DXCM
DXCM
WDAY
WDAY
Q1 26
$2.7B
Q4 25
$2.7B
$8.9B
Q3 25
$2.7B
$9.2B
Q2 25
$2.6B
$8.9B
Q1 25
$2.3B
$9.0B
Q4 24
$2.1B
$8.6B
Q3 24
$2.0B
$8.3B
Q2 24
$2.4B
$8.2B
Total Assets
DXCM
DXCM
WDAY
WDAY
Q1 26
$6.3B
Q4 25
$6.3B
$17.8B
Q3 25
$7.5B
$18.0B
Q2 25
$7.3B
$17.2B
Q1 25
$6.8B
$18.0B
Q4 24
$6.5B
$16.4B
Q3 24
$6.4B
$16.2B
Q2 24
$6.8B
$15.9B
Debt / Equity
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
WDAY
WDAY
Operating Cash FlowLast quarter
$588.0M
Free Cash FlowOCF − Capex
$550.0M
FCF MarginFCF / Revenue
22.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
2.33×
TTM Free Cash FlowTrailing 4 quarters
$2.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
$294.0M
$588.0M
Q3 25
$659.9M
$616.0M
Q2 25
$303.0M
$457.0M
Q1 25
$183.8M
$1.1B
Q4 24
$301.4M
$406.0M
Q3 24
$199.5M
$571.0M
Q2 24
$279.4M
$372.0M
Free Cash Flow
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
$192.1M
$550.0M
Q3 25
$579.4M
$588.0M
Q2 25
$208.9M
$421.0M
Q1 25
$96.8M
$1.0B
Q4 24
$176.8M
$359.0M
Q3 24
$88.3M
$516.0M
Q2 24
$213.3M
$291.0M
FCF Margin
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
15.3%
22.6%
Q3 25
47.9%
25.0%
Q2 25
18.1%
18.8%
Q1 25
9.3%
46.4%
Q4 24
15.9%
16.6%
Q3 24
8.9%
24.7%
Q2 24
21.2%
14.6%
Capex Intensity
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
8.1%
1.6%
Q3 25
6.7%
1.2%
Q2 25
8.1%
1.6%
Q1 25
8.4%
3.9%
Q4 24
11.2%
2.2%
Q3 24
11.2%
2.6%
Q2 24
6.6%
4.1%
Cash Conversion
DXCM
DXCM
WDAY
WDAY
Q1 26
Q4 25
1.10×
2.33×
Q3 25
2.33×
2.70×
Q2 25
1.69×
6.72×
Q1 25
1.74×
11.83×
Q4 24
1.99×
2.10×
Q3 24
1.48×
4.33×
Q2 24
1.95×
3.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

WDAY
WDAY

Subscription Services$2.2B92%
Professional Services$188.0M8%

Related Comparisons